Oncimmune Holdings plc Banner Image

Oncimmune Holdings plc

  • Ticker ONC
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Oncimmune Holdings plc Logo Image
  • 51-200 Employees
  • Based in Nottingham, England
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers that can help stratify patients in multiple cancer indicationsMore, infectious diseases, and with various autoimmune diseases; and NavigAID disease-specific stratification panels. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
4.8 / 5.0 (93)

Oncimmune Holdings plc reports have an aggregate usefulness score of 4.8 based on 93 reviews.

Oncimmune Holdings plc

Most Recent Annual Report

Oncimmune Holdings plc
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Oncimmune Holdings plc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!